Search Results 2291-2300 of 14789 for anti-TNF drugs

1. ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) - Mayo Clinic

   randomization. 8. Stable or decreasing dose of corticosteroids and anti-seizure medications for 7 days prior to randomization, if applicable. Stable steroid ...

2. Discovery's Edge: Plugging into drug discovery - Mayo Clinic News Network

   ... drugs. Drug development out of reach for Mayo Clinic. Dr. Bram was well aware that the next steps in creating a therapy for brain cancers based on his ...

3. Phase 1/2, Open-label, Dose-escalation Study of ISIS-STAT3Rx, Administered to Patients with Advanced Cancers - Mayo Clinic

   Tumors that are relapsed or refractory to at least 1 prior anti-cancer systemic therapy and for which no standard therapy exists; Expansion cohort only ...

4. Teclistamab-Cqyv (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

5. Oncolytic Adenovirus for Cancer Therapy - Virology, Vector and Vaccine Engineering: Michael A. Barry - Mayo Clinic Research

   These agents have the appeal of being "self-amplifying" drugs, because each infected tumor cell produces 10,000 more viruses to amplify the number of killed ...

6. Dactinomycin (Intravenous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Betamethasone And Calcipotriene (Topical Application Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

8. Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer - Mayo Clinic

   By condition, treatment or drug name. Search tips. Study of TH-302 or ... Inability to discontinue non-steroidal anti-inflammatory drugs for 5 days ...

9. Education and Training - Drug Discovery, Design and Optimization for Novel Therapeutics: Thomas Caulfield - Mayo Clinic Research

   In the example presented featuring the PMM2 gene, over 1,500 missense variants were generated for protein structures. Then structural dynamics studies were ...

10. Ado-Trastuzumab Emtansine (Intravenous Route) Precautions - Mayo Clinic

    Your doctor may test your heart before and during treatment. Contact your doctor right away if you have chest pain, increased coughing, trouble breathing, rapid ...